Cerebain Biotech (CBBT) Jumps Another 47%: What’s The Buzz?

When a stock records considerable gains over many months, then it is perhaps time for investors to take note of the stock in question. The Cerebain Biotech (OTC: CBBT) stock has been one of the biggest gainers in recent months and on Tuesday, the rally continued.

Yesterday, the stock soared by another 47% to takes its total gains since October 2020 to as much as 1000%. That being said, it should be noted that there has been no recent news about the company that could have brought about such a strong rally in the Cerebain stock.

Related:  ChemoCentryx (CCXI) Stock Slumps 45% on FDA Briefing Documents

The genesis of the rally in the stock perhaps lies in development from back in November last year. At the time, the company announced that PKG Inc has been contracted to be the manufacturer of Clear Mask LLC and Xometry. Clear Mask is a completely transparent surgical mask and remains the only mask of its kind that has been approved by the United States Food and Drug Administration.

Anthony Gonzales

Biotech, Tech, and Crypto reporter Anthony Gonzales brings 3 years of experience in helping grassroots, mid-sized organizations and large institutions strengthen their management and resource generating capacities and effectively plan for the future. He is also a mentor and professional advisor to artists working in all disciplines. He is the gold medalist from St. Marco University of Science and Technology in the Bachelors of Financial Management as well.